李正雄, 王雅棣. 长链非编码RNA FTH1P3靶向miR-218降低人肺癌顺铂耐药细胞对顺铂的化疗敏感性[J]. 中国肿瘤临床, 2021, 48(12): 595-602. DOI: 10.3969/j.issn.1000-8179.2021.12.221
引用本文: 李正雄, 王雅棣. 长链非编码RNA FTH1P3靶向miR-218降低人肺癌顺铂耐药细胞对顺铂的化疗敏感性[J]. 中国肿瘤临床, 2021, 48(12): 595-602. DOI: 10.3969/j.issn.1000-8179.2021.12.221
Zhengxiong Li, Yadi Wang. Long non-coding RNA FTH1P3 reduces cisplatin-resistant human lung cancer cell chemosensitivity to cisplatin by targeting miR-218[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 48(12): 595-602. DOI: 10.3969/j.issn.1000-8179.2021.12.221
Citation: Zhengxiong Li, Yadi Wang. Long non-coding RNA FTH1P3 reduces cisplatin-resistant human lung cancer cell chemosensitivity to cisplatin by targeting miR-218[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 48(12): 595-602. DOI: 10.3969/j.issn.1000-8179.2021.12.221

长链非编码RNA FTH1P3靶向miR-218降低人肺癌顺铂耐药细胞对顺铂的化疗敏感性

Long non-coding RNA FTH1P3 reduces cisplatin-resistant human lung cancer cell chemosensitivity to cisplatin by targeting miR-218

  • 摘要:
      目的  研究长链非编码RNA铁蛋白重链1假基因3(ferritin heavy chain 1 pseudogene 3,FTH1P3)对人肺癌顺铂(cisplatin,DDP)耐药细胞株(A549/DDP)DDP化疗敏感性的影响,并探究其潜在的分子机制。
      方法  采用荧光定量PCR检测FTH1P3与miR-218在A549和A549/DDP细胞中的表达。采用MTT法、流式细胞术、Hoechst 33258染色及CASP3活性试验评估细胞对DDP化疗敏感性的影响。采用荧光素酶报告基因和RNA蛋白免疫沉淀试验分析FTH1P3对miR-218的调控作用。
      结果  与A549细胞相比,A549/DDP细胞中FTH1P3表达上调,而miR-218表达下调(P<0.05)。与si-NC相比,si-FTH1P3增加A549/DDP细胞对DDP的化疗敏感性,表现为半抑制浓度(IC50)降低,多药耐药关联蛋白1(multidrug resistance-associated protein 1,MRP1)和ATP结合家族亚家族B成员1(ATP binding cassette subfamily B member 1,ABCB1)mRNA表达下调,细胞生长能力降低、凋亡增加及CASP3活性升高(P<0.05)。FTH1P3直接结合miR-218并抑制其表达(P<0.05)。与NC 抑制物相比,miR-218 抑制物能够逆转经si-FTH1P3处理的A549/DDP细胞对DDP的化疗敏感性(P<0.05)。
      结论  FTH1P3在A549/DDP细胞中表达上调,FTH1P3降低A549/DDP细胞对DDP的化疗敏感性,其机制与miR-218表达下调有关。

     

    Abstract:
      Objective  To investigate the effect of long non-coding RNA ferritin heavy chain 1 pseudogene 3 (FTH1P3) on the chemosensitivityof a human lung cancer cisplatin (DDP)-resistant cell line (A549/DDP) to DDP and to explore the potential underlying molecular mechanisms.
      Methods  We used quantitative real-time PCR to detect the expression of FTH1P3 and miR-218 in the A549 and A549/DDP cells. We performed MTT assay, flow cytometry analysis, Hoechst 33258 staining, and Caspase-3 activity assay to evaluate the DDP chemosensitivity of the A549/DDP cells. We analyzed the regulatory effect of FTH1P3 on miR-218 via luciferase reporter gene and RNA immunoprecipitation assays.
      Results  Compared with the A549 cells, the FTH1P3 and miR-218 expressions were up- and downregulated (P<0.05) in the A549/DDP cells, respectively. Compared with the si-NC, si-FTH1P3 increased the DDP chemosensitivity of the A549/DDP cells, showing reduced half-maximal inhibitory concentration (IC50), downregulated multidrug resistance-associated protein 1 (MRP1) and ATP-binding cassette subfamilyB member 1 (ABCB1) mRNA expressions, reduced cell growth ability, and increased apoptosis and CASP3 activity (P<0.05). Moreover, FTH1P3 directly bound to miR-218 and inhibited its expression (P<0.05). Compared with NC-inhibitors, miR-218 inhibitors reversed the DDP chemosensitivity of si-FTH1P3-treated A549/DDP cells (P<0.05).
      Conclusions  FTH1P3 expression was upregulated in A549/DDP cells, reducing the DDP chemosensitivity of A549/DDP cells through miR-218 expression downregulation-related effect or mechanism.

     

/

返回文章
返回